Detalhe da pesquisa
1.
Validation of Dual-Action Chemo-Radio-Labeled Nanocarriers with High Efficacy against Triple-Negative Breast Cancer.
ACS Appl Mater Interfaces
; 15(42): 48963-48977, 2023 Oct 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37831583